Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

NCT00498433 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Early termination resulted from interim analysis of the ALTITUDE trial

Conditions

Hypertension
Abdominal Obesity

Interventions

DRUG: Aliskiren
DRUG: Amlodipine
DRUG: Placebo of Aliskiren
DRUG: Placebo of amlodipine

Sponsor

Novartis